Shigella spp. antimicrobial drug resistance, Papua New Guinea, 2000-2009.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Antimicrobial Resistance in Papua New Guinea: A Narrative Scoping Review.Antibiotics (Basel, Switzerland) · 2023
   Article
2. Antibiotic Resistance in Pacific Island Countries and Territories: A Systematic Scoping Review.Antibiotics (Basel, Switzerland) · 2019
   Article
3. A large outbreak of shigellosis commencing in an internally displaced population, Papua New Guinea, 2013.Western Pacific surveillance and response journal : WPSAR · 2014
   Article
4. Mobile phone-based syndromic surveillance system, Papua New Guinea.Emerging infectious diseases · 2013
   Article
5. Laboratory-based prospective surveillance for community outbreaks of Shigella spp. in Argentina.PLoS neglected tropical diseases · 2013
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

7 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as